Cargando…

Early Prediction of Tumor Response to Neoadjuvant Chemotherapy and Clinical Outcome in Breast Cancer Using a Novel FDG-PET Parameter for Cancer Stem Cell Metabolism

Cancer stem cells (CSCs) contribute to chemoresistance and tumor relapse. By using the distinct metabolic phenotype of CSC, we designed novel PET parameters for CSC metabolism and investigated their clinical values. Patients with breast cancer who underwent (18)F-FDG PET/CT before neoadjuvant chemot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Chanwoo, Han, Sang-Ah, Won, Kyu Yeoun, Hong, Il Ki, Kim, Deog Yoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565130/ https://www.ncbi.nlm.nih.gov/pubmed/32957507 http://dx.doi.org/10.3390/jpm10030132

Ejemplares similares

Mesonephric Adenocarcinoma of the Uterine Fundus Exhibiting High (18)F-FDG Uptake
por: Kim, Hyung Kyung, et al.
Publicado: (2020)

Early Assessment of Response to Neoadjuvant Chemotherapy with (18)F-FDG-PET/CT in Patients with Advanced-Stage Ovarian Cancer
por: Chung, Young Shin, et al.
Publicado: (2020)

Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy
por: Keam, Bhumsuk, et al.
Publicado: (2011)

Diagnostic and Predictive Values of (18)F-FDG PET/CT Metabolic Parameters in EGFR-Mutated Advanced Lung Adenocarcinoma
por: Hong, Il Ki, et al.
Publicado: (2020)

Treatment Response Evaluation of Breast Cancer after Neoadjuvant Chemotherapy and Usefulness of the Imaging Parameters of MRI and PET/CT
por: An, Yeong Yi, et al.
Publicado: (2015)

Early prediction of neoadjuvant chemotherapy response for advanced breast cancer using PET/MRI image deep learning
por: Choi, Joon Ho, et al.
Publicado: (2020)

Early response monitoring of neoadjuvant chemotherapy using [(18)F]FDG PET can predict the clinical outcome of extremity osteosarcoma
por: Lee, Inki, et al.
Publicado: (2020)

Prediction of Neoadjuvant Chemotherapy Response in Osteosarcoma Using Convolutional Neural Network of Tumor Center (18)F-FDG PET Images
por: Kim, Jingyu, et al.
Publicado: (2021)

Prognostic value of complete metabolic response on (18)F-FDG-PET/CT after three cycles of neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer
por: Chung, Young Shin, et al.
Publicado: (2022)

Metabolic Radiomics for Pretreatment (18)F-FDG PET/CT to Characterize Locally Advanced Breast Cancer: Histopathologic Characteristics, Response to Neoadjuvant Chemotherapy, and Prognosis
por: Ha, Seunggyun, et al.
Publicado: (2017)

Co-clinical FDG-PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple-negative breast cancer
por: Roy, Sudipta, et al.
Publicado: (2021)

Prediction of pathological response after neoadjuvant chemotherapy using baseline FDG PET heterogeneity features in breast cancer
por: Oliveira, Carla, et al.
Publicado: (2023)

The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas
por: Palmerini, Emanuela, et al.
Publicado: (2016)

Feasibility of FDG PET/CT to monitor the response of axillary lymph node metastases to neoadjuvant chemotherapy in breast cancer patients
por: Straver, Marieke E., et al.
Publicado: (2010)

Monitoring tumor response to neoadjuvant chemotherapy using MRI and (18)F-FDG PET/CT in breast cancer subtypes
por: Schmitz, Alexander M. Th., et al.
Publicado: (2017)

Predicting Response to Neoadjuvant Chemotherapy Using 18F FDG PET-CT in Patients with Locally Advanced Breast Cancer
por: Hulikal, Narendra, et al.
Publicado: (2020)

Correction to: Co‑clinical FDG‑PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple‑negative breast cancer
por: Roy, Sudipta, et al.
Publicado: (2021)

Clinicopathologic parameters associated with the FDG-avidity in staging of early gastric cancer using (18)F-FDG PET
por: Yoon, Joon-Kee, et al.
Publicado: (2019)

Development and External Validation of (18)F-FDG PET-Based Radiomic Model for Predicting Pathologic Complete Response after Neoadjuvant Chemotherapy in Breast Cancer
por: Lim, Chae Hong, et al.
Publicado: (2023)

Predictive Value of [(18)F]FDG PET/CT for Lymph Node Metastasis in Rectal Cancer
por: Kim, Sung Hoon, et al.
Publicado: (2019)

Multiparametric (18)F-FDG PET/MRI-Based Radiomics for Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
por: Umutlu, Lale, et al.
Publicado: (2022)

The Value of (18)F-FDG PET/CT Imaging in the Evaluation of Interim Neoadjuvant Chemotherapy Response in Locally Advanced Breast Cancer
por: Tatar, Gamze, et al.
Publicado: (2022)

(18)F-FDG PET Metabolic Parameters and MRI Perfusion and Diffusion Parameters in Hepatocellular Carcinoma: A Preliminary Study
por: Ahn, Sung Jun, et al.
Publicado: (2013)

FDG-PET parameters predicting mediastinal malignancy in lung cancer
por: Serra Fortuny, M., et al.
Publicado: (2016)

Clinical correlation of metabolic parameters on (18)F-FDG PET/CT in idiopathic frozen shoulder
por: Won, Kyoung Sook, et al.
Publicado: (2017)

The Value of Semiquantitative Parameters Derived from (18)F-FDG PET/CT for Predicting Response to Neoadjuvant Chemotherapy in a Cohort of Patients with Different Molecular Subtypes of Breast Cancer
por: Urso, Luca, et al.
Publicado: (2022)

Prognostic value of (18)F-FDG PET and PET/CT for assessment of treatment response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis
por: Han, Sangwon, et al.
Publicado: (2020)

Value of [(18)F]FDG PET/CT radiomic parameters in the context of response to chemotherapy in advanced cervical cancer
por: Burchardt, Ewa, et al.
Publicado: (2023)

Evaluation of lymph node status after neoadjuvant chemotherapy in breast cancer patients: comparison of diagnostic performance of ultrasound, MRI and (18)F-FDG PET/CT
por: You, S, et al.
Publicado: (2015)

Detection of Recurrence by (18)F-FDG PET in Patients with Endometrial Cancer Showing No Evidence of Disease
por: Ryu, Sang-Young, et al.
Publicado: (2010)

Implication of FDG-PET/CT without synchronous colonic lesion in patients with stenotic left-sided colorectal cancer
por: Lee, Jong Il, et al.
Publicado: (2021)

(18)F-FDG PET-Derived Volume-Based Parameters to Predict Disease-Free Survival in Patients with Grade III Breast Cancer of Different Molecular Subtypes Candidates to Neoadjuvant Chemotherapy
por: Quartuccio, Natale, et al.
Publicado: (2023)

FDG-PET/CT lymph node staging after neoadjuvant chemotherapy in patients with adenocarcinoma of the esophageal–gastric junction
por: Fencl, Pavel, et al.
Publicado: (2016)

Neoadjuvant intra-arterial chemotherapy combined with radiotherapy and surgery in patients with advanced maxillary sinus cancer
por: Kim, Won Taek, et al.
Publicado: (2013)

18F-FDG-PET/MRI texture analysis in rectal cancer after neoadjuvant chemoradiotherapy
por: Capelli, Giulia, et al.
Publicado: (2022)

(18)FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort study
por: Schneider, Paul M., et al.
Publicado: (2018)

Metabolic Super Scan in (18)F-FDG PET/CT Imaging
por: Kim, Dae-Weung, et al.
Publicado: (2010)

Ki-67 as a Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
por: Kim, Kwan Il, et al.
Publicado: (2014)

The role of interim FDG PET-CT after induction chemotherapy as a predictor of concurrent chemoradiotherapy efficacy and prognosis for head and neck cancer
por: Kim, Ka-Rham, et al.
Publicado: (2017)

Characteristics of thyroid incidentalomas detected by pre-treatment [(18)F]FDG PET or PET/CT in patients with cervical cancer
por: Lee, Won-Moo, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_m15hnupahdghaltcssop4e5url